Table 6.
Prognostic factors for overall survival
| Factor | Univariable analysis |
Multivariable analysis |
||
|---|---|---|---|---|
| HR | P-value | HR | P-value | |
| Recipient age | 0.988 | 0.497 | - | - |
| Male sex | 1.748 | 0.198 | - | - |
| Donor age | 1.019 | 0.063 | - | - |
| AFP level >50 ng/mL | 2.329 | 0.006 | 2.120 (1.127–3.987) | 0.020 |
| LDLT | 0.616 | 0.083 | - | - |
| Tumor size >3 cm | 1.866 | 0.029 | 1.329 (0.668–2.642) | 0.417 |
| Number of tumors | 1.045 | 0.018 | 1.059 (1.013–1.106) | 0.011 |
| MELD score | 1.037 | 0.022 | 1.044 (1.007–1.083) | 0.019 |
| Exceeding Milan criteria | 1.936 | 0.022 | - | - |
| Everolimus use | 0.238 | 0.001 | 0.145 (0.055–0.381) | <0.001 |
| Microscopic vascular invasion | 2.451 | 0.001 | 1.976 (1.073–3.640) | 0.029 |
HR, hazard ratio; CI, confidence interval; AFP, alpha-fetoprotein; LDLT, living donor liver transplantation; MELD, model for end-stage liver disease.